Torl Biotherapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTorl Biotherapeutics
Torl Biotherapeutics logo

Torl Biotherapeutics

0 followers

About Torl Biotherapeutics

Torl Biotherapeutics is a clinical-stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Dennis Slamon

Scientific Co-founder

Key Facts

HQ Location

Culver City, United States

Founded

2018

Employees

11 - 50

Status

Private

Website

https://torlbio.com